Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Efficacy of educational intervention on reducing the inappropriate use of oral third-generation cephalosporins.

Uda A, Kimura T, Nishimura S, Ebisawa K, Ohji G, Kusuki M, Yahata M, Izuta R, Sakaue T, Nakamura T, Koike C, Tokimatsu I, Yano I, Iwata K, Miyara T.

Infection. 2019 Oct 11. doi: 10.1007/s15010-019-01362-x. [Epub ahead of print]

PMID:
31605309
2.

The incidence of endophthalmitis or macular involvement and the necessity of a routine ophthalmic examination in patients with candidemia.

Ueda T, Takesue Y, Tokimatsu I, Miyazaki T, Nakada-Motokawa N, Nagao M, Nakajima K, Mikamo H, Yamagishi Y, Kasahara K, Yoshihara S, Ukimura A, Yoshida K, Yoshinaga N, Izumi M, Kakeya H, Yamada K, Kawamura H, Endou K, Yamanaka K, Yoshioka M, Amino K, Ikeuchi H, Uchino M, Miyazaki Y.

PLoS One. 2019 May 23;14(5):e0216956. doi: 10.1371/journal.pone.0216956. eCollection 2019.

3.

Selection of oral antifungals for initial maintenance therapy in chronic pulmonary aspergillosis: A longitudinal analysis.

Tashiro M, Takazono T, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Kakeya H, Ando T, Ogawa K, Kishi K, Tokimatsu I, Hayashi Y, Fujiuchi S, Yanagihara K, Miyazaki Y, Ichihara K, Mukae H, Kohno S, Izumikawa K.

Clin Infect Dis. 2019 Apr 9. pii: ciz287. doi: 10.1093/cid/ciz287. [Epub ahead of print]

PMID:
30959519
4.

Bacteremia complicating urinary tract infection by Pseudomonas aeruginosa: Mortality risk factors.

Kitagawa K, Shigemura K, Yamamichi F, Osawa K, Uda A, Koike C, Tokimatsu I, Shirakawa T, Miyara T, Fujisawa M.

Int J Urol. 2019 Mar;26(3):358-362. doi: 10.1111/iju.13872. Epub 2018 Dec 21.

PMID:
30575137
5.

Acquisition of antimicrobial-resistant variants in repeated infections caused by Pseudomonas aeruginosa revealed by whole genome sequencing.

Nakanishi N, Nomoto R, Sato K, Koike C, Kusuki M, Nakamura T, Shigemura K, Shirakawa T, Fujisawa M, Tokimatsu I, Osawa K.

J Infect Chemother. 2019 Feb;25(2):154-156. doi: 10.1016/j.jiac.2018.07.016. Epub 2018 Aug 17.

PMID:
30126693
6.

The development of diffuse panbronchiolitis during the treatment with long-term, low-dose clarithromycin for chronic sinusitis.

Ando M, Ono T, Usagawa Y, Yoshikawa H, Hirano T, Tokimatsu I, Kadota JI.

J Infect Chemother. 2019 Feb;25(2):147-150. doi: 10.1016/j.jiac.2018.07.011. Epub 2018 Aug 7.

PMID:
30097373
7.

Invasive Scopulariopsis alboflavescens infection in patient with acute myeloid leukemia.

Kurata K, Nishimura S, Ichikawa H, Sakai R, Mizutani Y, Takenaka K, Kakiuchi S, Miyata Y, Kitao A, Yakushijin K, Kawamoto S, Yamamoto K, Ito M, Matsuoka H, Tokimatsu I, Kamei K, Minami H.

Int J Hematol. 2018 Dec;108(6):658-664. doi: 10.1007/s12185-018-2496-1. Epub 2018 Jul 9.

PMID:
29987744
8.

Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan.

Tokimatsu I, Shigemura K, Osawa K, Kinugawa S, Kitagawa K, Nakanishi N, Yoshida H, Arakawa S, Fujisawa M; Research Group of Japan Infection Prevention and Control Conference for National and Public University Hospitals.

J Infect Chemother. 2018 Aug;24(8):641-647. doi: 10.1016/j.jiac.2018.03.015.

PMID:
29685855
9.

Risk factors for death from Stenotrophomonas maltophilia bacteremia.

Osawa K, Shigemura K, Kitagawa K, Tokimatsu I, Fujisawa M.

J Infect Chemother. 2018 Aug;24(8):632-636. doi: 10.1016/j.jiac.2018.03.011. Epub 2018 Apr 16.

PMID:
29673561
10.

Determination of the antimicrobial susceptibility and molecular profile of clarithromycin resistance in the Mycobacterium abscessus complex in Japan by variable number tandem repeat analysis.

Kusuki M, Osawa K, Arikawa K, Tamura M, Shigemura K, Shirakawa T, Nakamura T, Nakamachi Y, Fujisawa M, Saegusa J, Tokimatsu I.

Diagn Microbiol Infect Dis. 2018 Jul;91(3):256-259. doi: 10.1016/j.diagmicrobio.2018.02.008. Epub 2018 Feb 18.

PMID:
29550059
11.

Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedback.

Kimura T, Uda A, Sakaue T, Yamashita K, Nishioka T, Nishimura S, Ebisawa K, Nagata M, Ohji G, Nakamura T, Koike C, Kusuki M, Ioroi T, Mukai A, Abe Y, Yoshida H, Hirai M, Arakawa S, Yano I, Iwata K, Tokimatsu I.

Infection. 2018 Apr;46(2):215-224. doi: 10.1007/s15010-017-1099-8. Epub 2017 Nov 13.

PMID:
29134582
12.

Comparison of antibiotics use, urinary tract infection (UTI)-causative bacteria and their antibiotic susceptibilities among 4 hospitals with different backgrounds and regions in Japan.

Shigemura K, Kitagawa K, Osawa K, Yamamichi F, Tokimatsu I, Nomi M, Takaba K, Fujisawa M.

J Chemother. 2018 Feb;30(1):31-36. doi: 10.1080/1120009X.2017.1376817. Epub 2017 Sep 28.

PMID:
28956738
13.
14.

Improved bacterial identification directly from urine samples with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Kitagawa K, Shigemura K, Onuma KI, Nishida M, Fujiwara M, Kobayashi S, Yamasaki M, Nakamura T, Yamamichi F, Shirakawa T, Tokimatsu I, Fujisawa M.

J Clin Lab Anal. 2018 Mar;32(3). doi: 10.1002/jcla.22301. Epub 2017 Jul 24.

PMID:
28737838
15.

A Prospective Study of the Efficacy, Safety and Pharmacokinetics of Enteral Moxifloxacin in the Treatment of Hemodialysis Patients with Pneumonia.

Tokimatsu I, Shigemura K, Kotaki T, Yoshikawa H, Yamamichi F, Tomo T, Arakawa S, Fujisawa M, Kadota JI.

Intern Med. 2017;56(11):1315-1319. doi: 10.2169/internalmedicine.56.8369. Epub 2017 Jun 1.

16.

Shock due to urosepsis: A multicentre study.

Yamamichi F, Shigemura K, Kitagawa K, Takaba K, Tokimatsu I, Arakawa S, Fujisawa M.

Can Urol Assoc J. 2017 Mar-Apr;11(3-4):E105-E109. doi: 10.5489/cuaj.4097. Epub 2017 Mar 16.

17.

A New Amino Acid Substitution at G150S in Lanosterol 14-α Demethylase (Erg11 protein) in Multi-azole-resistant Trichosporon asahii.

Kushima H, Tokimatsu I, Ishii H, Kawano R, Watanabe K, Kadota JI.

Med Mycol J. 2017;58(1):E23-E28. doi: 10.3314/mmj.16-00027.

18.

Should We Change the Initial Treatment of Renal or Retroperitoneal Abscess in High Risk Patients?

Yamamichi F, Shigemura K, Kitagawa K, Arakawa S, Tokimatsu I, Fujisawa M.

Urol Int. 2017;98(2):222-227. doi: 10.1159/000454887. Epub 2017 Feb 3.

PMID:
28152534
19.

[The Deveroppment of Screening Methods Using the Disk Diffusion Method for Carbapenemase-producing Enterobacteriaceae].

Nakamura T, Kobayashi S, Onuma K, Kusuki M, Hayashi N, Oji G, Tokimatsu I, Saegusa J, Arakawa S.

Kansenshogaku Zasshi. 2017 Jan;91(1):14-9. Japanese.

PMID:
30277682
20.

Executive Summary of Japanese Domestic Guidelines for Management of Deep-seated Mycosis 2014.

Kohno S, Tamura K, Niki Y, Izumikawa K, Oka S, Ogawa K, Kadota J, Kamei K, Kanda Y, Kiuchi T, Shibuya K, Takakura S, Takata T, Takesue Y, Teruya K, Tokimatsu I, Fukuda T, Maesaki S, Makimura K, Mikamo H, Mitsutake K, Miyazaki Y, Mori M, Yasuoka A, Yano K, Yamanaka N, Yoshida M.

Med Mycol J. 2016;57(4):E117-E163. Review. No abstract available.

21.

Invasive Pulmonary Aspergillosis Presenting with Tracheobronchial Involvement.

Kushima H, Tokimatsu I, Ishii H, Kadota J.

Intern Med. 2016;55(12):1679. doi: 10.2169/internalmedicine.55.6822. Epub 2016 Jun 15. No abstract available.

22.

[Antifungal susceptibility and drug-resistant mechanism of Trichosporon].

Kushima H, Tokimatsu I, Ishii H, Kadota J.

Med Mycol J. 2015;56(4):J123-8. doi: 10.3314/mmj.56.J123. Review. Japanese.

23.

Effects of Sulfamethoxazole-Trimethoprim on Airway Colonization with Pneumocystis jirovecii.

Kushima H, Ishii H, Tokimatsu I, Umeki K, Sato T, Kadota J.

Jpn J Infect Dis. 2016 May 20;69(3):252-5. doi: 10.7883/yoken.JJID.2014.546. Epub 2015 Aug 7.

24.

Significance of High Trough Concentration of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection.

Sato Y, Tokimatsu I, Suzuki Y, Itoh H, Hiramatsu K, Kadota J.

Chemotherapy. 2014;60(4):274-8. doi: 10.1159/000381634. Epub 2015 Apr 25.

PMID:
25926288
25.

Optimal vancomycin doses for methicillin-resistant Staphylococcus aureus infection in urological renal dysfunction patients.

Shigemura K, Osawa K, Yamamichi F, Tanaka K, Tokimatsu I, Arakawa S, Fujisawa M.

Int Urol Nephrol. 2015 Jun;47(6):887-91. doi: 10.1007/s11255-015-0973-5. Epub 2015 Apr 22.

PMID:
25899764
26.

Association of overexpression of efflux pump genes with antibiotic resistance in Pseudomonas aeruginosa strains clinically isolated from urinary tract infection patients.

Shigemura K, Osawa K, Kato A, Tokimatsu I, Arakawa S, Shirakawa T, Fujisawa M.

J Antibiot (Tokyo). 2015 Sep;68(9):568-72. doi: 10.1038/ja.2015.34. Epub 2015 Apr 8.

PMID:
25850341
27.

A retrospective analysis to estimate target trough concentration of vancomycin for febrile neutropenia in patients with hematological malignancy.

Suzuki Y, Tokimatsu I, Morinaga Y, Sato Y, Takano K, Kohno K, Ogata M, Hiramatsu K, Itoh H, Kadota J.

Clin Chim Acta. 2015 Feb 2;440:183-7. doi: 10.1016/j.cca.2014.11.027. Epub 2014 Dec 2.

PMID:
25476135
28.

Efficacy and safety of levofloxacin in patients with bacterial pneumonia evaluated according to the new "Clinical Evaluation Methods for New Antimicrobial Agents to Treat Respiratory Infections (Second Version)".

Mukae H, Kawanami T, Yatera K, Yanagihara K, Yamamoto Y, Kakeya H, Tokimatsu I, Kadota J, Kohno S.

J Infect Chemother. 2014 Jul;20(7):417-22. doi: 10.1016/j.jiac.2014.03.009. Epub 2014 Apr 29.

PMID:
24787737
29.

Exophiala dermatitidis pneumonia successfully treated with long-term itraconazole therapy.

Mukai Y, Nureki S, Hata M, Shigenaga T, Tokimatsu I, Miyazaki E, Kadota J, Yarita K, Kamei K.

J Infect Chemother. 2014 Jul;20(7):446-9. doi: 10.1016/j.jiac.2014.02.006. Epub 2014 Apr 22.

PMID:
24767462
30.

Clinical practice guidelines for therapeutic drug monitoring of arbekacin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.

Okada K, Kimura T, Mikamo H, Kasahara K, Seki M, Takakura S, Tokimatsu I, Ohmagari N, Takahashi Y, Matsumoto K, Igarashi M, Kobayashi M, Hamada Y, Mochizuki T, Kimura M, Nishi Y, Tanigawara Y, Takesue Y; Japanese Society of Chemotherapy; Japanese Society of Therapeutic Drug Monitoring.

J Infect Chemother. 2014 Jan;20(1):1-5. doi: 10.1016/j.jiac.2013.08.008. Epub 2013 Dec 11.

31.

Inhibitory effects of pitavastatin on fibrogenic mediator production by human lung fibroblasts.

Oka H, Ishii H, Iwata A, Kushima H, Toba S, Hashinaga K, Umeki K, Tokimatsu I, Hiramatsu K, Kadota J.

Life Sci. 2013 Dec 18;93(25-26):968-74. doi: 10.1016/j.lfs.2013.10.026. Epub 2013 Nov 6.

PMID:
24211780
32.

Fungemia due to Trichosporon dermatis in a patient with refractory Burkitt's leukemia.

Hashino S, Takahashi S, Morita R, Kanamori H, Onozawa M, Kawamura T, Kahata K, Kondo T, Tokimatsu I, Sugita T, Akizawa K, Asaka M.

Blood Res. 2013 Jun;48(2):154-6. doi: 10.5045/br.2013.48.2.154. Epub 2013 Jun 25. No abstract available.

33.

Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity.

Suzuki Y, Tokimatsu I, Sato Y, Kawasaki K, Sato Y, Goto T, Hashinaga K, Itoh H, Hiramatsu K, Kadota J.

Clin Chim Acta. 2013 Sep 23;424:119-22. doi: 10.1016/j.cca.2013.05.025. Epub 2013 Jun 6.

PMID:
23747486
34.

Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan.

Kohno S, Yanagihara K, Yamamoto Y, Tokimatsu I, Hiramatsu K, Higa F, Tateyama M, Fujita J, Kadota J.

J Infect Chemother. 2013 Dec;19(6):1035-41. doi: 10.1007/s10156-013-0618-5. Epub 2013 May 22.

PMID:
23695232
35.

Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.

Hamada Y, Tokimatsu I, Mikamo H, Kimura M, Seki M, Takakura S, Ohmagari N, Takahashi Y, Kasahara K, Matsumoto K, Okada K, Igarashi M, Kobayashi M, Mochizuki T, Nishi Y, Tanigawara Y, Kimura T, Takesue Y.

J Infect Chemother. 2013 Jun;19(3):381-92. doi: 10.1007/s10156-013-0607-8. Epub 2013 May 15. No abstract available.

36.

Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.

Matsumoto K, Takesue Y, Ohmagari N, Mochizuki T, Mikamo H, Seki M, Takakura S, Tokimatsu I, Takahashi Y, Kasahara K, Okada K, Igarashi M, Kobayashi M, Hamada Y, Kimura M, Nishi Y, Tanigawara Y, Kimura T.

J Infect Chemother. 2013 Jun;19(3):365-80. doi: 10.1007/s10156-013-0599-4. Epub 2013 May 15. No abstract available.

37.

[Trichosporonosis].

Tokimatsu I.

Med Mycol J. 2012;53(3):169-74. Review. Japanese. No abstract available.

38.

Is peak concentration needed in therapeutic drug monitoring of vancomycin? A pharmacokinetic-pharmacodynamic analysis in patients with methicillin-resistant staphylococcus aureus pneumonia.

Suzuki Y, Kawasaki K, Sato Y, Tokimatsu I, Itoh H, Hiramatsu K, Takeyama M, Kadota J.

Chemotherapy. 2012;58(4):308-12. doi: 10.1159/000343162. Epub 2012 Nov 7.

39.

Bronchial stump aspergillosis after stapled lobectomy for lung cancer.

Tokuishi K, Yamashita S, Hashimoto T, Moroga T, Miyawaki M, Chujo M, Yamamoto S, Kawahara K, Tokimatsu I, Kashima K.

Ann Thorac Surg. 2012 Oct;94(4):1324-6. doi: 10.1016/j.athoracsur.2012.02.079.

PMID:
23006687
40.

Physicians' attitudes toward the definition of "death from age-related physical debility" in deceased elderly with aspiration pneumonia.

Komiya K, Ishii H, Kushima H, Sato S, Kimura H, Yasuda T, Okabe E, Tokimatsu I, Yamamoto H, Kadota J.

Geriatr Gerontol Int. 2013 Jul;13(3):586-90. doi: 10.1111/j.1447-0594.2012.00941.x. Epub 2012 Sep 19.

PMID:
22994861
41.

Thin-section CT findings in Pseudomonas aeruginosa pulmonary infection.

Okada F, Ono A, Ando Y, Nakayama T, Ishii R, Sato H, Kira A, Tokimatsu I, Kadota J, Mori H.

Br J Radiol. 2012 Dec;85(1020):1533-8. doi: 10.1259/bjr/54468236. Epub 2012 Jul 27.

42.

Prognostic significance of serum β-d-glucan levels in 78 patients with Trichosporon fungemia.

Kushima H, Ishii H, Komiya K, Tokimatsu I, Kadota J.

Int J Infect Dis. 2013 Feb;17(2):e134-5. doi: 10.1016/j.ijid.2012.05.1038. Epub 2012 Jul 23. No abstract available.

43.

Cloning of the lanosterol 14-α-demethylase ( ERG11 ) gene in Trichosporon asahii: a possible association between G453R amino acid substitution and azole resistance in T. asahii.

Kushima H, Tokimatsu I, Ishii H, Kawano R, Shirai R, Kishi K, Hiramatsu K, Kadota J.

FEMS Yeast Res. 2012 Sep;12(6):662-7. doi: 10.1111/j.1567-1364.2012.00816.x. Epub 2012 Jun 18.

44.

Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells.

Iwata A, Shirai R, Ishii H, Kushima H, Otani S, Hashinaga K, Umeki K, Kishi K, Tokimatsu I, Hiramatsu K, Kadota J.

Clin Exp Immunol. 2012 May;168(2):234-40. doi: 10.1111/j.1365-2249.2012.04564.x.

45.

Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia.

Umeki K, Tokimatsu I, Yasuda C, Iwata A, Yoshioka D, Ishii H, Shirai R, Kishi K, Hiramatsu K, Matsumoto B, Kadota J.

Respirology. 2011 Jul;16(5):856-61. doi: 10.1111/j.1440-1843.2011.01983.x.

PMID:
21545370
46.

[Current anti-influenza virus chemotherapy].

Yoshioka D, Tokimatsu I, Ishii H, Kadota J.

Nihon Rinsho. 2010 Sep;68(9):1679-84. Review. Japanese.

PMID:
20845747
47.

A Japanese adult case of forme fruste cystic fibrosis.

Oka H, Ishii H, Kishi K, Yokoyama A, Komiya K, Otani S, Yoshioka D, Shirai R, Tokimatsu I, Hiramatsu K, Kadota J.

Intern Med. 2010;49(12):1251-2. Epub 2010 Jun 15. No abstract available.

48.

[Allergic bronchopulmonary mycosis induced by Schizophyllum commune--case report and review of the literature].

Amemiya Y, Shirai R, Tokimatsu I, Oka H, Iwata A, Otani S, Umeki K, Sakashita H, Ishii H, Gendo Y, Kishi K, Hiramatsu K, Kadota J.

Nihon Kokyuki Gakkai Zasshi. 2009 Aug;47(8):692-7. Review. Japanese.

PMID:
19764511
49.

Tracheobronchial amyloidosis in a patient with sarcoidosis.

Oka H, Ishii H, Iwasaki T, Amemiya Y, Otani S, Yoshioka D, Kishi K, Shirai R, Tokimatsu I, Kadota J.

Intern Med. 2009;48(18):1715-6. Epub 2009 Sep 15. No abstract available.

50.

A Japanese family with multiple lung cysts and recurrent pneumothorax: a possibility of Birt-Hogg-Dubé syndrome.

Ishii H, Oka H, Amemiya Y, Iwata A, Otani S, Kishi K, Shirai R, Tokimatsu I, Kawahara K, Kadota J.

Intern Med. 2009;48(16):1413-7. Epub 2009 Aug 17.

Supplemental Content

Loading ...
Support Center